|
1
|
European Association For The Study Of The
Liver; European Organisation For Research And Treatment Of Cancer:
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and epidemiology of hepatocellular
carcinoma: A global and regional perspective. Oncologist. 15(Suppl
4): S5–S13. 2010. View Article : Google Scholar
|
|
3
|
Bae JS, Noh SJ, Jang KY, Park HS, Chung
MJ, Park CK and Moon WS: Expression and role of epithelial cell
adhesion molecule in dysplastic nodule and hepatocellular
carcinoma. Int J Oncol. 41:2150–2158. 2012.PubMed/NCBI
|
|
4
|
Schulze K, Gasch C, Staufer K, Nashan B,
Lohse AW, Pantel K, Riethdorf S and Wege H: Presence of
EpCAM-positive circulating tumor cells as biomarker for systemic
disease strongly correlates to survival in patients with
hepatocellular carcinoma. Int J Cancer. 133:2165–2171. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chan AW, Tong JH, Chan SL, Lai PB and To
KF: Expression of stemness markers (CD133 and EpCAM) in
prognostication of hepatocellular carcinoma. Histopathology.
64:935–950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamashita T, Ji J, Budhu A, Forgues M,
Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, et al:
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating
cells with stem/progenitor cell features. Gastroenterology.
136:1012–1024. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad
A, Banerjee S, Azmi AS, Miele L and Sarkar FH: Notch-1 induces
epithelial-mesenchymal transition consistent with cancer stem cell
phenotype in pancreatic cancer cells. Cancer Lett. 307:26–36. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nishina S, Shiraha H, Nakanishi Y, Tanaka
S, Matsubara M, Takaoka N, Uemura M, Horiguchi S, Kataoka J,
Iwamuro M, et al: Restored expression of the tumor suppressor gene
RUNX3 reduces cancer stem cells in hepatocellular carcinoma by
suppressing Jagged1-Notch signaling. Oncol Rep. 26:523–531.
2011.PubMed/NCBI
|
|
9
|
van der Gun BT, Melchers LJ, Ruiters MH,
de Leij LF, McLaughlin PM and Rots MG: EpCAM in carcinogenesis: The
good, the bad or the ugly. Carcinogenesis. 31:1913–1921. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Patriarca C, Macchi RM, Marschner AK and
Mellstedt H: Epithelial cell adhesion molecule expression (CD326)
in cancer: A short review. Cancer Treat Rev. 38:68–75. 2012.
View Article : Google Scholar
|
|
11
|
Wu SD, Ma YS, Fang Y, Liu LL, Fu D and
Shen XZ: Role of the microenvironment in hepatocellular carcinoma
development and progression. Cancer Treat Rev. 38:218–225. 2012.
View Article : Google Scholar
|
|
12
|
Brabletz T: To differentiate or not -
routes towards metastasis. Nat Rev Cancer. 12:425–436. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okamoto K, Tajima H, Nakanuma S, Sakai S,
Makino I, Kinoshita J, Hayashi H, Nakamura K, Oyama K, Nakagawara
H, et al: Angiotensin II enhances epithelial-to-mesenchymal
transition through the interaction between activated hepatic
stellate cells and the stromal cell-derived factor-1/CXCR4 axis in
intra-hepatic cholangiocarcinoma. Int J Oncol. 41:573–582.
2012.PubMed/NCBI
|
|
14
|
Kim SW, Choi HJ, Lee HJ, He J, Wu Q,
Langley RR, Fidler IJ and Kim SJ: Role of the endothelin axis in
astrocyte- and endothelial cell-mediated chemoprotection of cancer
cells. Neuro Oncol. 16:1585–1598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kikuta K, Masamune A, Watanabe T, Ariga H,
Itoh H, Hamada S, Satoh K, Egawa S, Unno M and Shimosegawa T:
Pancreatic stellate cells promote epithelial-mesenchymal transition
in pancreatic cancer cells. Biochem Biophys Res Commun.
403:380–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hellerbrand C: Hepatic stellate cells -
the pericytes in the liver. Pflugers Arch. 465:775–778. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Osta WA, Chen Y, Mikhitarian K, Mitas M,
Salem M, Hannun YA, Cole DJ and Gillanders WE: EpCAM is
overexpressed in breast cancer and is a potential target for breast
cancer gene therapy. Cancer Res. 64:5818–5824. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Coulouarn C, Corlu A, Glaise D, Guénon I,
Thorgeirsson SS and Clément B: Hepatocyte-stellate cell cross-talk
in the liver engenders a permissive inflammatory microenvironment
that drives progression in hepatocellular carcinoma. Cancer Res.
72:2533–2542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Friedman SL: Hepatic stellate cells:
Protean, multifunctional, and enigmatic cells of the liver. Physiol
Rev. 88:125–172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amann T, Bataille F, Spruss T, Mühlbauer
M, Gäbele E, Schölmerich J, Kiefer P, Bosserhoff AK and Hellerbrand
C: Activated hepatic stellate cells promote tumorigenicity of
hepatocellular carcinoma. Cancer Sci. 100:646–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ju MJ, Qiu SJ, Fan J, Xiao YS, Gao Q, Zhou
J, Li YW and Tang ZY: Peritumoral activated hepatic stellate cells
predict poor clinical outcome in hepatocellular carcinoma after
curative resection. Am J Clin Pathol. 131:498–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Samatov TR, Tonevitsky AG and Schumacher
U: Epithelial-mesenchymal transition: Focus on metastatic cascade,
alternative splicing, non-coding RNAs and modulating compounds. Mol
Cancer. 12:1072013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tse JC and Kalluri R: Mechanisms of
metastasis: Epithelial-to-mesenchymal transition and contribution
of tumor microenvironment. J Cell Biochem. 101:816–829. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Watanabe T, Shibata N, Westerman KA,
Okitsu T, Allain JE, Sakaguchi M, Totsugawa T, Maruyama M,
Matsumura T, Noguchi H, et al: Establishment of immortalized human
hepatic stellate scavenger cells to develop bioartificial livers.
Transplantation. 75:1873–1880. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kang N, Gores GJ and Shah VH: Hepatic
stellate cells: Partners in crime for liver metastases? Hepatology.
54:707–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hashiguchi M, Ueno S, Sakoda M, Iino S,
Hiwatashi K, Minami K, Ando K, Mataki Y, Maemura K, Shinchi H, et
al: Clinical implication of ZEB-1 and E-cadherin expression in
hepatocellular carcinoma (HCC). BMC Cancer. 13:5722013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kimura O, Kondo Y, Kogure T, Kakazu E,
Ninomiya M, Iwata T, Morosawa T and Shimosegawa T: Expression of
EpCAM increases in the hepatitis B related and the
treatment-resistant hepatocellular carcinoma. BioMed Res Int.
2014:1729132014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Oishi N, Yamashita T and Kaneko S:
Molecular biology of liver cancer stem cells. Liver Cancer.
3:71–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
